PharmatrophiX
PrivateLast Round
Grant
Jan 5, 2016
Total Funding Raised
$2.88M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
PharmatrophiX is a clinical-stage biopharmaceutical company that develops disease-modifying small molecule drugs targeting mechanisms underlying neurodegenerative disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PharmatrophiX Comparables
Compare PharmatrophiX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gismo Therapeutics | 82% | |
| Spinogenix, Inc. | 81% | |
| Priavoid | 74% |
PharmatrophiX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 5, 2016 | ||||
| VC Round | Oct 6, 2014 | ||||
| Grant | Jul 1, 2013 | ||||
| Debt | Aug 29, 2012 | ||||
| Grant | Oct 1, 2009 | ||||
Grant | Feb 1, 2008 |
PharmatrophiX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dolby Family Ventures | VC Round |
| S-Cubed Capital | VC Round |
| Piedmont Capital Investments | VC Round |
| Alzheimer's Association | Grant |
| Alzheimer's Drug Discovery Foundation | Grant, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 76% MoM.
- Jul 26, 2026
Monthly visitors grew 34% MoM.
Recent news
Latest coverage and updates
- attends_eventJul 14, 2026
PharmatrophiX attends event Alzheimer's Association International Conference.
PharmatrophiX Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PharmatrophiX's valuation, stock price, and market status.
Is PharmatrophiX a public or private company?
PharmatrophiX is a private company.
What is the current stock price of PharmatrophiX?
PharmatrophiX is a private company with no public stock price. No recent secondary market data is available.
How much is PharmatrophiX worth (valuation)?
Valuation information for PharmatrophiX is not publicly available.
Can I buy PharmatrophiX stock?
PharmatrophiX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was PharmatrophiX's last funding round?
PharmatrophiX's most recent funding round was Grant on September 12, 2024.
Who are the main investors in PharmatrophiX?
Key investors in PharmatrophiX include Dolby Family Ventures, Alzheimer's Drug Discovery Foundation.
Will PharmatrophiX IPO soon?
No public IPO plans have been announced for PharmatrophiX.
How can I track PharmatrophiX secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PharmatrophiX's secondary market activity and sign up for updates.